Hidrasec Children (Racecadotril)

Hidrasec Children is indicated for the symptomatic relief of acute diarrhea in pediatric patients. It is used to reduce stool frequency and fluid loss, helping to maintain hydration and comfort during short‑term gastrointestinal upset.

• Treatment of acute, non‑bloody diarrhea in children
• Adjunct to oral rehydration therapy to limit fluid loss
• Management of watery stools caused by viral gastroenteritis
• Supportive care for mild to moderate diarrheal episodes in infants and toddlers
• Use in conjunction with dietary measures to restore normal bowel function

• Racecadotril, the active component of Hidrasec Children, is an enkephalinase inhibitor. By blocking the enzyme that degrades endogenous enkephalins, it increases the local concentration of these peptides in the intestinal mucosa. The elevated enkephalins activate opioid receptors on enteric neurons, which reduces the secretion of water and electrolytes into the gut lumen, thereby decreasing stool output without affecting intestinal motility.

Adverse reactions to Hidrasec Children are generally uncommon, but they can occur. Patients and caregivers should be aware of both frequent and rare events.

Common

• Mild abdominal discomfort or cramps
• Nausea or transient vomiting
• Headache
• Dizziness
• Mild rash or skin irritation

Serious

• Allergic reactions such as urticaria, angioedema, or anaphylaxis
• Severe skin reactions (e.g., Stevens‑Johnson syndrome)
• Persistent vomiting leading to dehydration
• Signs of hypersensitivity (e.g., swelling of face, lips, tongue)

Before using Hidrasec Children, consider the following safety points. The product is intended for short‑term use and should not replace medical evaluation for severe or persistent diarrhea.

• Verify the child’s age and weight to ensure appropriate use
• Avoid use in children with known hypersensitivity to racecadotril or any excipients
• Do not use if diarrhea is accompanied by high fever, blood in stool, or signs of dehydration
• Consult a healthcare professional if diarrhea persists longer than 48‑72 hours
• Use alongside oral rehydration solutions to maintain fluid balance
• Keep out of reach of children to prevent accidental ingestion of excessive amounts

While Hidrasec Children has a limited interaction profile, certain substances may affect its safety or efficacy.

Avoid

• Concurrent use of other antidiarrheal agents (e.g., loperamide) without medical advice
• Administration with opioid analgesics that could potentiate central opioid effects

Use with caution

• Antacids that may alter gastrointestinal pH and affect drug absorption
• Medications that prolong QT interval, though evidence is limited
• Herbal supplements affecting gut motility (e.g., senna, cascara)
• Broad‑spectrum antibiotics that may change gut flora and diarrhea etiology